Cover Story
Free
It takes a few clicks to look up the name of a company that holds the “Abbreviated New Drug Application,” or ANDA, to make a generic drug. Alas, this information is of little value.
In Brief
Trending Stories
- Edward Sondik, electrical engineer turned public health expert and one-time interim NCI director, dies at 82
- High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward
NCI’s Youth Enjoy Science (YES) program also invests in student scientists - Trump et al. are wrong: Biden Cancer Initiative is not to be confused with the Beau Biden Cancer Moonshot
- NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- At White House forum, Bertagnolli, Califf, Wegrzyn call for greater innovation in clinical trials